BioDeeptech Intelligence v2.4 ยท Global
5 DB LIVE
โœจ Precision Bio Intelligence for Medical Researchers & VC Analysts Save $3,000/yr DB Subscriptions

Stop Scraping PubMed All Night.
Instant 16:9 Multi-Omics Decks in Seconds.

Cross-validated across 5 global databases (Open Targets, PubMed, UniProt, ChEMBL, ClinicalTrials.gov).
Get prioritized target scores, mechanism trends, and clinical pipeline due diligence for just $10 per 3-in-1 Suite.

๐Ÿงฌ Target Confidence Radar: APP vs PSEN1 (MONDO_0004975)
LIVE SYNCED
APP amyloid beta precursor
0.872 Score
Literature Evidence
0.997
Clinical Validation
0.977
Genetic Association
0.923
PSEN1 presenilin 1
0.867 Score
Genetic Literature
0.888
Clinical Validation
0.977
Literature Support
0.994
๐Ÿ’ก Complete target pipelines across 5 diseases available in 16:9 executive presentation decks.
Multi-Disease Target Intelligence

Alzheimer's Disease Target Matrix

Prioritized multi-dimensional validation scores from Open Targets Platform official records.

Rank Target Symbol Approved Name Overall Score Literature Evidence Clinical Phase Dossier
Commercial Intelligence Store

Verified Multi-Omics Target Research Suites

Institution-grade intelligence suites. 1 Free Lead Magnet ($0) + 4 Commercial Suites ($10.00 each).

๐Ÿ“„

9-Page A4 Whitepaper

Nature/McKinsey-grade publication dossier for academic submission & printing.

๐Ÿ“Š

16:9 Presentation Deck

Ready-to-present executive slide deck for seminar & lab meeting decks.

๐Ÿ“‘

Raw Multi-Omics CSV/JSON

Full target scores, Ensembl IDs, and clinical trial matrices for Python/Excel.

๐Ÿ“œ

Patent & TAM Market Maps

Composition-of-matter expiry (2026-2038) & 2033 TAM projections.

๐ŸŽ Free Lead Magnet ($0) FREE / $0
Alzheimer 3D Render
Alzheimer's 3-in-1 Research Suite
APP ยท PSEN1 ยท TREM2 9-Page Full Suite

Alzheimer's Multi-Omics Research Suite

9-page comprehensive dossier: Multi-omics genetic scoring, 3D structural pockets, patent expiry timeline, and global market projections.

  • โœ“ 9-Page A4 Research Whitepaper (PDF)
  • โœ“ 16:9 Presentation Slides & Raw Dataset (CSV/JSON/ZIP)
๐Ÿ“ฅ Download Free 3-in-1 Suite ($0)
Instant Download $10.00 / 3-in-1 Suite
Parkinson 3D Render
Parkinson's Research Suite
SNCA ยท LRRK2 ยท PRKN 9-Page A4 + Data

Parkinson's Alpha-Synuclein & LRRK2 Suite

SNCA propagation, LRRK2 Rab phosphorylation dynamics, GCase allosteric chaperones, and clinical neuroprotection pipeline due diligence.

  • โœ“ 9-Page A4 Research Whitepaper & Due Diligence Matrix
  • โœ“ 3D Pockets, Patent Expiry Map & Raw CSV/JSON Dataset
Instant Download $10.00 / 3-in-1 Suite
Pancreatic Cancer 3D Render
Pancreatic Cancer Suite
KRAS ยท TP53 ยท SMAD4 9-Page A4 + Data

Pancreatic Cancer KRAS Inhibitors Suite

Non-covalent KRAS G12D/V switch-II binders, FAK/TGF-ฮฒ stroma remodeling, and personalized mRNA neoantigen vaccine combinations.

  • โœ“ 9-Page A4 Research Whitepaper & Due Diligence Matrix
  • โœ“ 3D Pockets, Patent Expiry Map & Raw CSV/JSON Dataset
Instant Download $10.00 / 3-in-1 Suite
Glioblastoma 3D Render
Glioblastoma Research Suite
EGFRvIII ยท PTEN ยท IDH1 9-Page A4 + Data

Glioblastoma BBB Penetration & RMT Suite

EGFRvIII truncated kinase signaling, TfR receptor-mediated transcytosis (RMT), IDH1 2-HG inhibitors, and dual-target locoregional CAR-T.

  • โœ“ 9-Page A4 Research Whitepaper & Due Diligence Matrix
  • โœ“ 3D Pockets, Patent Expiry Map & Raw CSV/JSON Dataset
Instant Download $10.00 / 3-in-1 Suite
NSCLC Lung Cancer 3D Render
NSCLC Precision Oncology Suite
4th Gen TKI ยท TROP2 ADC 9-Page A4 + Data

NSCLC 4th-Gen TKI & Next-Gen ADC Suite

C797S triple-mutation resistance breakers, MET bypass pathways, and TROP2/HER3 ADC combination trial pipelines.

  • โœ“ 9-Page A4 Research Whitepaper & Due Diligence Matrix
  • โœ“ 3D Pockets, Patent Expiry Map & Raw CSV/JSON Dataset
Executive 16:9 Deck Reader

Alzheimer's Disease Target Report Preview

Slide 1 of 3
PART 1 ยท CORE GENETIC TARGETS

Alzheimer's Disease: Core Target Genes

TARGET #1

APP (Amyloid Beta Precursor)

Open Targets Association Score: 0.872. Fundamental driver of amyloid-beta plaque deposition with 0.99 literature and clinical validation.

TARGET #2

PSEN1 (Presenilin 1)

Association Score: 0.867. Catalytic subunit of gamma-secretase complex and primary genetic determinant of familial early-onset Alzheimer's.

TAKEAWAY

Therapeutic Mainstream Strategy

Modulating or inhibiting mutations and cleaved byproducts of these two genes remains the primary backbone of global clinical pipelines.

Data Source: Open Targets Platform (5 DB Live) Page 1 / 3 (Free Preview Available)
PART 2 ยท LITERATURE INSIGHTS

Recent Research Trends (PubMed NLP Summary)

TREND #1

APP Transcriptional Control & Cellular Senescence

Rapid surge in investigations linking microglial senescence pathways directly with APP expression modulation beyond simple amyloid clearance.

TREND #2

Tau Dysfunction Synergy Mechanisms

Targeting molecular axes where APP fragments accelerate tauopathy has emerged as a cornerstone for next-generation combination therapies.

PubMed Synthesis

Multi-Mechanism Targeting

Combining neuro-inflammation regulation with proteostasis restoration is gaining significant traction to surpass single-antibody limits.

Data Source: NCBI PubMed E-Utilities NLP Pipeline Page 2 / 3
PART 3 ยท INVESTMENT & CLINICAL STRATEGY

Investment / Clinical Strategy Insights

Pipeline Landscape

APP / PSEN1 Competitive Density

High big-pharma density on validated targets creates premium valuation upside for biotech platforms with proprietary BBB-crossing delivery systems.

Emerging Axes

Dual Targeting: Senescence & Microglia

Early-stage investment opportunities favor startups restoring immune homeostasis alongside classic amyloid suppression.

VC Checklist

5-DB Score Filtering

Utilize genomic target concordance (Score > 0.8) across global databases as a primary due diligence filter before term-sheet issuance.

BioDeeptech Proprietary Intelligence Analysis Page 3 / 3 (Full Report Available)
Methodology & Data Pipeline

5-Global Database Cross-Validation Engine

Every target association is systematically cross-referenced across authoritative worldwide bio repositories.

๐Ÿงฌ

Open Targets Platform

EMBL-EBI & Sanger Institute

GraphQL API Integration
โ†’
๐Ÿ“š

NCBI PubMed

National Library of Medicine

E-utilities NLP Pipeline
โ†’
โšก

Gemini LLM Synthesizer

Multi-Omics Synthesis & 16:9 Structuring

Prompt Engine v2.4
โ†’
๐Ÿ“„

Chrome Headless PDF

1920x1080 Vector Rendering

100% Lossless Deck
ENSG00000142192

APP

amyloid beta precursor protein

0.87 Overall Score
This target possesses verified scientific association on Open Targets Platform.

Multi-Dimensional Score Breakdown